| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Articles |
a Vertebrate Biocontrol Cooperative Research Centre, CSIRO Wildlife and Ecology, Canberra, ACT, 2601, Australia
Development of immunocontraceptives for wild rabbit populations requires selection of both effective antigens and effective delivery systems. Recombinant rabbit zona pellucida glycoprotein B (ZPB) produced in eukaryotic cells in vitro was an effective antigen and induced sustained infertility in 70% of female rabbits. This required two boosts and serum antibody titers of 12 800 or greater. Antibody titers in females were low after the initial immunization, as might be expected with a self-antigen; however, male rabbits had a strong antibody response, indicating that the protein was immunologically foreign. To develop a delivery system, ZPB was delivered by infection with a recombinant myxoma virus. In contrast to the results with ZPB protein, infection of rabbits induced a similar serum antibody response to ZPB in both sexes. This indicated that presentation of ZPB in the context of a virus infection was able to overcome tolerance in females. However, the antibody titers were lower than 12 800, and only 25% of female rabbits were infertile. This antibody response was boosted by injections of recombinant ZPB protein, after which 80% of female rabbits were infertile. Infertility was associated with antibody binding to zonae and varying degrees of ovarian pathology characterized by follicular degeneration and substantial depletion of primordial follicles. Oocyte and follicular degeneration appeared to be the principal mechanism of infertility and may be primarily induced by antibodies to ZPB.
This article has been cited by other articles:
|
|
 |
|
  J. A Eade, I. D Roberston, and C. M James Contraceptive potential of porcine and feline zona pellucida A, B and C subunits in domestic cats Reproduction, June 1, 2009; 137(6): 913 - 922. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A Duckworth, K. Wilson, X. Cui, F. C Molinia, and P. E Cowan Immunogenicity and contraceptive potential of three infertility-relevant zona pellucida 2 epitopes in the marsupial brushtail possum (Trichosurus vulpecula) Reproduction, January 1, 2007; 133(1): 177 - 186. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. W Cooper and E. Larsen Immunocontraception of mammalian wildlife: ecological and immunogenetic issues. Reproduction, December 1, 2006; 132(6): 821 - 828. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.M. Mackenzie, E.A. McLaughlin, H.D. Perkins, N. French, T. Sutherland, R.J. Jackson, B. Inglis, W.J. Muller, B.H. van Leeuwen, A.J. Robinson, et al. Immunocontraceptive Effects on Female Rabbits Infected with Recombinant Myxoma Virus Expressing Rabbit ZP2 or ZP3 Biol Reprod, March 1, 2006; 74(3): 511 - 521. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Clydesdale, J. Pekin, S. Beaton, R. J Jackson, S. Vignarajan, and C. M Hardy Contraception in mice immunized with recombinant zona pellucida subunit 3 proteins correlates with Th2 responses and the levels of interleukin 4 expressed by CD4+ cells Reproduction, December 1, 2004; 128(6): 737 - 745. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R.-L. Xiang, F. Zhou, Y. Yang, and J.-P. Peng Construction of the Plasmid pCMV4-rZPC' DNA Vaccine and Analysis of Its Contraceptive Potential1 Biol Reprod, May 1, 2003; 68(5): 1518 - 1524. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Mulryan, M. G. Ryan, K. A. Myers, D. Shaw, W. Wang, S. M. Kingsman, P. L. Stern, and M. W. Carroll Attenuated Recombinant Vaccinia Virus Expressing Oncofetal Antigen (Tumor-associated Antigen) 5T4 Induces Active Therapy of Established Tumors Mol. Cancer Ther., October 1, 2002; 1(12): 1129 - 1137. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. S. Dunbar, S. Prasad, C. Carino, and S. M. Skinner The Ovary as an Immune Target Reproductive Sciences, January 1, 2001; 8(1_suppl): S43 - S48. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
